Sign in
Enrolling by invitationNo phase

Tests a decision aid tool for choosing ways to put liver care into practice

Tests a decision aid for choosing strategies to improve care for cirrhosis and liver cancer.

Key facts

Who runs it
VA Office of Research and Development
Where
Pittsburgh, United StatesSee the site
Trial code
Registry title
Project OASIS: Optimizing Approaches to Select Implementation Strategies
Status
Enrolling by invitation
People taking part
8,020 people, planned
Started
1 Feb 2024
Expected to end
31 Oct 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • OASIS DA training
  • Current DA Tool training
Record updated
4 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for Veterans with cirrhosis (or its complications) treated at a participating VA medical center, and VA clinicians and staff who choose ways to improve care there.

Age
18 Years and older
Sex
All sexes can join.
Disease stage
Cirrhosis or its complications, shown by two outpatient or one inpatient diagnosis codes.
Earlier treatment
Veterans must have had a visit at a participating VA medical center in the prior 18 months. Veterans after a transplant cannot join.

Main reasons for not taking part

  • Veterans after a transplant
  • Veterans with active hepatocellular carcinoma

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Veterans:
  • Veterans with two outpatient or one inpatient codes for cirrhosis or its complications who had an encounter in the prior 18 months at a participating VA medical center; VA clinicians:
  • Physicians, advance practice providers, nurses, leadership, and staff engaged with selecting and applying implementation strategies to improve care at a participating VA medical center

Who cannot take part

  • Veterans post-transplant or with active hepatocellular carcinoma

Where in United States

  • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PAPittsburgh, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Barriers that prevent healthcare methods supported by science from being adopted in the real world have led to low-quality, inequitable medical care. Implementation science aims to bridge the evidence-to-practice gap but still lacks simple and convenient methods to identify implementation barriers, systematically track which strategies work to improve care, and provide accessible data and expert recommendations to guide implementation strategy selection for use in research and practice. Project OASIS (Optimizing Approaches to Select Implementation Strategies) will conduct a hybrid type-III, cluster-randomized trial of a new decision aid tool that matches site variables and barriers to successful implementation strategies.

The 2 groups in the trial

  • OASIS DATreatment being tested

    Half of the sites will be randomized to receive training on the OASIS decision aid.

    Treatment: OASIS DA training

  • Current DA ToolExisting treatment, for comparison

    Half of the sites will be randomized to receive training on the current decision aid tool.

    Treatment: Current DA Tool training

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Project OASIS: Optimizing Approaches to Select Implementation Strategies
Plain-language title
Tests a decision aid tool for choosing ways to put liver care into practiceGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
4 February 2026